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Abstract
Integrins play an important role in tumour progression
by influencing cellular responses and matrix-depend-
ent adhesion. However, the regulation of matrix -
dependent adhesion assembly in epithelial cells is
poorly understood. We have investigated the integrin
and signalling requirements of cell–matrix adhesion
assembly in colon carcinoma cells after plating on
fibronectin. Adhesion assembly in these, and in the
adenoma cells from which they were derived, was
largely dependent on v6 integrin and required
phosphorylation of FAK on tyrosine-397. The rate of
fibronectin- induced adhesion assembly and the ex-
pression of both v6 integrin and FAK were increased
during the adenoma-to-carcinoma transition. The ma-
trix-dependent adhesion assembly process, particu-
larly the final stages of complex protrusion that is
required for optimal cell spreading, required the activity
of extracellular signal-regulated kinase (ERK). Further-
more, phosphorylated ERK was targeted to newly
forming cell–matrix adhesions in the carcinoma cells
but not the adenoma cells, and inhibition of FAK–
tyrosine-397 phosphorylation or MEK suppressed the
appearance of phosphorylated ERK at peripheral sites.
In addition, inhibition of MEK–ERK activation blocked
the formation of peripheral actin microspikes that were
necessary for the protrusive phase of cell–matrix
adhesion assembly. Thus, MEK–ERK–dependent pe-
ripheral actin re-organization is required for the full
development of integrin- induced adhesions and this
pathway is stimulated in an in vitro model of colon
cancer progression. Neoplasia (2001) 3, 215–226.
Keywords: integrin -mediated adhesion assembly, colon cancer, focal adhesion kinase,
extracellular signal - regulated kinase, actin cytoskeleton.
Introduction
Focal adhesions are specialized structures found in fibro-
blasts where cells contact their surrounding extracellular
matrix (ECM). They consist of clustered integrin hetero-
dimers, structural - or cytoskeletal -associated proteins that
link the ECM through the integrins to the actin cytoskeleton,
and proteins involved in intracellular signal transduction
(reviewed in Ref. [1 ] ). The dynamic regulation of the
assembly and disassembly of these structures governs the
ability of cells to respond to their extracellular environment,
thus regulating processes such as adhesion and motility. In
epithelial cells, similar matrix-dependent adhesion sites exist
although little is known about their regulation. In tumour cells
in vivo, the balance between adhesiveness and migration is
likely to be determined by the underlying matrix as well as the
integrins present on the tumour cell surface. While a
reduction in tumour cell matrix should aid migration and
tumorigenicity, the cells also require matrix adhesion to
derive traction for migration away from other cells. Thus,
deregulation of matrix -dependent adhesion assembly in
tumour cells alters tumour cell behaviour and may result in
more aggressive and invasive tumours.
In this study, we have examined matrix-dependent
adhesion assembly in an in vitro model of colon cancer
progression. In the model, a cell line was derived from a
familial adenoma (PC/AA), from which a non- tumorigenic
clonogenic variant was established (AA/C1). This adenoma
cell line was transformed in vitro to produce an anchorage-
independent adenocarcinoma line, which was tumorigenic
when injected into nude mice (AA/C1/SB10) [2 ]. Analysis
of the genetic and cellular changes that occur during this
conversion mimics those seen in vivo, indicating that this is
a relevant model for the study of cellular changes that occur
during the acquisition of a malignant phenotype [2,3 ]. Using
this model, we have identified changes in the regulation of
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integrin-dependent adhesion assembly during the ade-
noma-to-carcinoma transition. In addition, examination of
the matrix-dependent adhesion assembly process, which is
poorly understood in epithelial cells, identified specific
signalling requirements for the cytoskeletal re-arrange-
ments at the cell periphery that were required for the
protrusive final phase of the adhesion assembly process.
Integrins function not only as adhesion receptors, but also
play a role in activating intracellular signalling pathways.
Mediators of integrin- induced signalling include focal adhe-
sion kinase (FAK) and the Src family of tyrosine kinases,
which we have identified as possible mediators of epidermal
growth factor– induced invasion of AA/C1/SB10 colon
carcinoma cells [4 ]. Specifically, FAK is a key regulator of
cell spreading [5–7], focal adhesion turnover [8 ], and cell
motility [9,10]. It is rapidly phosphorylated on a number of
tyrosine residues after plating cells on matrix proteins [11–
14], including autophosphorylation of tyrosine-397 [15],
which plays a key role in integrin-mediated events such as
cell spreading and migration [5–7].
Extracellular signal - regulated kinase (ERK) activation is
also associated with numerous biological events including
integrin engagement [16–19], where it has been shown to
be downstream of FAK although this appears to be cell
type– and context -dependent. Recently, activated ERK has
been observed at newly forming focal adhesions in fibro-
blasts [20], which is consistent with a role for ERK signalling
in cell migration via phosphorylation of myosin light chain
kinase (MLCK) [21,22].
We set out to analyze the process of fibronectin- induced
adhesion assembly in the in vitro model of colon cancer
progression described, and to study the role of signalling
intermediates downstream of integrins in this process.
Fibronectin- induced adhesion assembly in the colon cancer
cells was mediated, at least in part, by v6 integrin that was
upregulated in the carcinoma cells. Furthermore, cell–matrix
adhesion assembly required phosphorylation of FAK on
tyrosine-397. In addition, activation of MEK–ERK was
required for the final protrusion of adhesion complexes that
had formed at the cell periphery. Specifically, ERK activation
was required for the generation of actin microspikes that
emanated from the peripheral cortical actin and mediated the
protrusion of adhesion complexes at the cell periphery and
optimal cell spreading.
Materials and Methods
Cell Culture and Transfections
The AA/C1 series of cell lines has been previously
described in detail [2 ]. Chicken FAK and FAK (Y397F)
both with a Myc tag at the carboxy terminus [23] were
removed from RCAS-FAK or RCAS-397F as ClaI frag-
ments, blunt -ended, and cloned into the EcoRV site of
pcDNA3.1 ( Invitrogen, Groningen, Netherlands). HA-ERK
was a kind gift from J. Pouyssegur [24]. Transient
transfections were carried out using Superfect according
to the manufacturer’s protocol (Qiagen, Crawley, UK).
Immunofluorescence
Permanox chamber slides were coated with fibronectin
(10 g/ml; Becton Dickinson, Oxford, UK) by overnight
incubation at 48C. All wells were incubated with 0.1% BSA for
2 hours at 378C to block non-specific binding and then
washed twice with phosphate-buffered saline (PBS). Cells
were then plated onto the coated chambers and allowed to
adhere for the indicated times. The medium was removed
and the cells fixed in 3.7% formaldehyde in PBS for 10
minutes at room temperature, permeabilized for 15 minutes
with 0.5% Triton X-100/1% BSA in PBS, and blocked for 30
minutes with 10% fetal bovine serum in PBS. The cells were
incubated with an anti–vinculin antibody (10 g/ml; Sigma,
Poole, UK) for 1 hour, washed in PBS, and then incubated
with anti–mouse FITC- labeled secondary antibody (Strat-
ech Scientific, Luton, UK). For visualization of Myc- tagged
FAK proteins, fixed cells were incubated with rabbit anti–Myc
antibody (10 g/ml; TCS Biologicals, Botolph, Claydon, UK)
and for detection of HA- tagged ERK, with mouse anti -HA (2
g/ml; Roche Diagnostics, Lewes, UK), then the appropriate
Texas Red labeled secondary antibody (Stratech Scientific,
Luton, UK). Detection of phospho-ERK was carried out as
described previously [20].
Cell–Matrix Adhesion Assembly
Permanoxchamber slideswerecoatedwith fibronectin (10
g/ml)byovernight incubationat48C.Allwellswere incubated
with0.1%BSAfor2hoursat378Ctoblocknon-specificbinding
and then washed twice with PBS. Cells were plated onto the
coatedchambersandallowed toattach for the indicated times.
The cells were then fixed and stained with anti–vinculin
antibodyasdescribedabove.Experimentswithantibodiesand
inhibitors were carried out in two ways. Either the cells were
allowed to attach for 30 minutes before their addition or the
cells were pre- incubated with them for 15 minutes prior to
attachment. Similar results were obtained in each case and
results are shown for the second procedure. Antibodies used
were anti -1 (mAb13, 5 g/ml; Becton Dickinson, Oxford,
UK), anti–v antibody (L230, ATCC hybridoma, 10 g/ml),
andanti -v6 (10D5, a kind gift fromDeanSheppard,UCSF,
10 g/ml). Inhibitor concentrations were PD098059 (25 M)
(Calbiochem,Nottingham,UK)andUO126(20M;Promega,
Southampton, UK). To monitor adhesion assembly on
immobilised v6 antisera, chambers were coated overnight
with rabbit anti–mouse IgG (10 g/ml), blocked in 0.1%
BSA, then incubated with anti–v6 antibody (E7P6, 10 g/
ml) for 2 hours at 378C before plating the cells.
Cell Attachment
Fibronectin (Becton Dickinson, Oxford, UK) and collagen
type IV (Sigma, Poole, UK) were used at a concentration of
10 g/ml to coat 96-well plates by overnight incubation at
48C. All wells were incubated with 0.1% BSA for 2 hours at
378C to block non-specific binding and then washed twice
with PBS. Cells were trypsinized and labeled with 51Cr by
incubation with 90 Ci sodium chromate (Amersham, Little
Chalfont, UK) in serum containing medium for 1 hour at
378C. Serum proteins and unincorporated 51Cr were
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removed by washing three times in serum-free medium. The
labeled cells were then resuspended in serum-free medium
and 1104 cells added to each well of the pre- treated plate.
After 1 hour, the non-attached cells were removed by
washing twice in PBS and the number of remaining attached
cells determined by counting the radioactivity on the bottom
of each well using a gamma counter. Non-specific attach-
ment was determined on wells coated with 0.1% BSA, which
was typically around 1% to 5% in both cell lines. This was
then subtracted from each value. The results were either
expressed as percentage attachment, where 100% attach-
ment corresponds to the total radioactivity added to each
well, or as percentage of control attachment in untreated
cells. Wells were set up in quadruplicate and the values are
the mean±SD taken from a representative experiment in a
series of at least three.
Immunoprecipitation and Immunoblotting
For FAK immunoprecipitation, cell extracts were prepared
in RIPA buffer (50 mM Tris pH 7.4, 150 mM sodium chloride,
5 mM EGTA, 0.1% SDS, 1% sodium deoxycholate, 1%
Triton X-100, 10 mM sodium pyrophosphate, 0.5 mM
sodium fluoride, 1 mM PMSF, 10 g/ml aprotinin, and 100
M sodium orthovanadate) and immunoprecipitated with
either saturating concentrations of anti–FAK antisera raised
against a C-terminal peptide [25] or phospho-FAK-Y397 (4
g [23] ). The immune complexes were collected on protein
A-Sepharose and washed five times with RIPA. Proteins
were separated by 7% SDS-PAGE and visualized after
blotting with either anti–FAK antibody (0.5 g/ml; Becton
Dickinson, Oxford, UK) or anti–phosphotyrosine antibody
(PY20, 1 g/ml; Becton Dickinson, Oxford, UK).
Fluorocytometric Analysis
Cells were trypsinized and resuspended in ice-cold wash
buffer (PBS supplemented with 0.1% BSA). Cells (2105)
were incubated with the appropriate integrin antibodies for 1
hour at 48C and then washed three times with wash buffer
before incubation with FITC- labeled secondary antibody for
30 minutes at 48C. After three washes in wash buffer, the
cells were fixed with 3.7% formaldehyde and stored at 48C
prior to analysis. Analysis was performed using a FACSCAN
analyzer (Becton Dickinson). Background fluorescence was
determined by omitting the primary antibody in one set of
samples. Antibodies used were anti -v5 (P1F6, 10 g/ml;
Chemicon, Harrow, UK) and anti -v6 (E7P6, a kind gift
from Dean Sheppard, UCSF, 10 g/ml).
Results
Cell–Matrix Adhesion Assembly on Fibronectin is Enhanced
during the Adenoma-to-Carcinoma Transition
We have examined the assembly of matrix -dependent
cellular adhesions in colorectal cancer cells (AA/C1/SB10)
and their adenoma progenitors (AA/C1). When these cells
spread after attaching to fibronectin, prominent vinculin -
containing protrusions (referred to from here as cell–matrix
adhesions) are assembled at the cell periphery (Figure 1A,
solid arrow ). In contrast, cells that have adhered to
fibronectin, but which have not spread, remain rounded
and are apparently tethered by a ring of vinculin-containing
smaller structures on the basal cell surface (Figure 1A,
broken arrow ). Using these criteria, we have quantitated
cell–matrix adhesion assembly on fibronectin by monitoring
the number of cells in the adherent population that have
peripheral vinculin -containing protrusions. We found that the
malignant colorectal cells, AA/C1/SB10, assembled cell–
matrix adhesions and spread more rapidly following adhe-
sion to fibronectin than the non-malignant cells, AA/C1,
from which they were derived (Figure 1B ). However, the
adhesion assembly process was unaltered between the two
cell lines following adhesion of the cells to collagen (Figure
1C ), indicating that the enhanced assembly of protruding
adhesions was matrix-specific. The difference in cell–matrix
adhesion assembly on fibronectin between the adenoma and
carcinoma cells was therefore not due to an intrinsic inability
of the adenoma cells to assemble such structures. The
difference in the adhesion assembly process between the
two cell lines was also not a result of differences in the ability
of the cells to attach, as there was no difference in
attachment to fibronectin between the two cell lines (Figure
1D ). In this experiment, we measured the number of cells
that attached to the matrix proteins after 1 hour regardless of
whether they had spread and assembled peripheral adhe-
sions. Thus, cell–matrix adhesion assembly can be moni-
tored independently of attachment to fibronectin and the
enhanced assembly of cell– fibronectin adhesion protrusions
accompanies the adenoma-to-carcinoma transition that
occurs in the in vitro model of colon cancer progression.
Cell–Matrix Adhesion Assembly on Fibronectin is Integrin-
Mediated
That the enhanced assembly of protruding adhesions was
matrix-dependent was confirmed by the observation that the
colorectal carcinoma cells contained no discernible vinculin-
containing structures after attachment to poly-L - lysine (not
shown). To ascertain which integrin heterodimer(s) was
responsible, we used previously characterized antibodies
that inhibit the ability of particular integrins to act as receptors
for their matrix ligands [26,27].
Using these antibodies, we previously demonstrated that
the attachment of both the AA/C1 and AA/C1/SB10 cells to
fibronectin was mediated by the 51 and v6 integrins
(results not shown). We therefore examined the involvement
of these integrins in the fibronectin-mediated adhesion
assembly process. The 6 inhibitory antibody suppressed
adhesion assembly by around 85% (similar results were also
seen with an v subunit inhibitory antibody), while there was
only around a 30% inhibition with the 1 inhibitory antibody
(Figure 2A ). Furthermore, clustering of the v6 integrin by
plating cells on immobilised v6 antibody clustered with
anti–mouse IgG was sufficient to induce adhesion assembly
(Figure 2B, top panel ). In contrast, very few cells adhered to
the chambers coated only with anti–mouse IgG and those
that did attach had no peripheral vinculin staining (Figure 2B,
bottom panel ). Thus, we concluded that fibronectin- induced
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adhesion assembly in the AA/C1/SB10 colon carcinoma
cells (and also in the AA/C1 adenoma progenitors, not
shown) was largely dependent on the function of v6
heterodimers, while the 1 integrin may play a lesser role.
v6 is also a receptor for vitronectin; however, for reasons
that are unexplained, neither of the cell lines was able to
adhere to vitronectin ( results not shown). Interestingly, we
found that v6 integrin expression was four- fold higher in
the carcinoma cells when compared to the adenoma cells
from which they were derived, with small changes in other
integrins known to act as receptors for fibronectin such as
v5, also seen between the two cell lines (Figure 2C ). The
increased cell surface expression of v6 may contribute to
the enhanced cell–matrix adhesion assembly that is
displayed by the AA/C1/SB10 cells on fibronectin (Figure
1B ), which we have shown to be largely inhibited by v6
blocking antibodies (Figure 2A ).
FAK Phosphorylation is Required for Cell–Matrix Adhesion
Assembly
We next investigated the signalling pathways that
regulate integrin-dependent assembly of cell–matrix adhe-
sions. One potential regulator of integrin-dependent adhe-
sion assembly is FAK, which is phosphorylated on tyrosine-
397 after plating cells on matrix proteins and is required for
FAK-mediated functions [5–7,28]. As we had previously
reported that protein levels of FAK were increased in the AA/
C1/SB10 carcinoma cells as compared to the AA/C1
adenoma cells [4 ], we addressed whether FAK tyrosine
phosphorylation was involved in integrin-mediated adhesion
assembly in the colon epithelial cells. We found that FAK was
tyrosine-phosphorylated after plating both the AA/C1 and
AA/C1/SB10 cells on fibronectin but not on poly-L - lysine
(Figure 3A, left hand, top panel ), although the level of
phosphorylation was greater in the AA/C1/SB10 cells. This
most likely reflects the increased expression of FAK in the
carcinoma cells (Figure 3A, left hand, bottom panel [4 ] ).
Furthermore, using an antibody, which specifically recog-
nises FAK phosphorylated on tyrosine-397 [23], we
demonstrated that this residue was phosphorylated in the
AA/C1/SB10 cells (Figure 3A, right hand panel ). Since
these cells cannot readily be stably transfected to express
exogenous proteins, we have used a combination of
transient transfection and drug treatment to further monitor
Figure 1. Cell –matrix adhesion assembly on fibronectin is enhanced during the progression of colon cancer. (A ) Visualization of AA /C1 /SB10 carcinoma cell –
matrix adhesion assembly 1 hour after plating on fibronectin. Cells were fixed and stained for vinculin. The solid arrow represents a spread cell with prominent
vinculin - containing protrusions, while the broken arrow represents an adherent, but non -spread cell which is tethered to the surface by a ring of small vinculin -
containing structures. Scale bar, 25 m. (B ) Cell –matrix adhesion assembly on fibronectin in AA /C1 and AA /C1 /SB10 cells was quantitated by counting the
percentage of cells with prominent adhesions in >500 adherent cells for the indicated times. Values are mean±SD from triplicate wells. (C ) Cell –matrix adhesion
assembly on collagen was measured by counting the percentage of cells with prominent focal adhesions in >500 cells. Values are mean±SD from triplicate wells.
(D ) Cell attachment to fibronectin and collagen was measured after 60 minutes. Values are mean±SD from quadruplicate wells.
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the cell–matrix adhesion assembly process on a single cell
basis. We therefore transiently transfected AA/C1/SB10
colon carcinoma cells with Myc- tagged FAK or a FAK-
Y397F mutant, and monitored the assembly of cell–matrix
adhesions. In cells expressing exogenous FAK-Y397F, the
number of cells that were able to assemble adhesions was
reduced to around 10% of that seen in the untransfected
control cells, while expression of the wild- type protein had no
effect (Figure 3B ). Using immunofluorescence, we demon-
strated that expression of the wild- type protein resulted in its
localization to cell–matrix adhesions co- incident with the
localization of vinculin at these sites (Figure 3C ). In contrast,
cells expressing the FAK-Y397F remained rounded with
diffuse staining for both vinculin and the myc- tagged mutant
FAK protein (Figure 3C ). These data indicate that integrin-
dependent cell spreading in AA/C1/SB10 colon carcinoma
cells is accompanied by FAK phosphorylation on tyrosine-
397, and that this is also required for fibronectin- induced
adhesion assembly.
Involvement of ERK in Cell–Matrix Adhesion Assembly on
Fibronectin
The ERK–MAP kinases have been implicated in the
regulation of cell migration [21,22] and are rapidly activated
following integrin engagement [16–19]. Furthermore, there
is a wide body of evidence implicating FAK in this process,
Figure 2. Cell –matrix adhesion assembly on fibronectin is integrin -mediated. (A ) Cell –matrix adhesion assembly in AA /C1 /SB10 cells on fibronectin was
measured by counting the percentage of cells with prominent adhesions in >500 cells in the presence of inhibitory integrin antibodies as indicated. Values are
mean±SD from triplicate wells. (B ) Cell –matrix adhesion assembly on v6 antibody and anti –mouse IgG coated chambers ( top panel ) or anti –mouse IgG
alone -coated chambers ( bottom panel ). (C ) Cell surface integrin expression was determined in the AA /C1 and AA /C1 /SB10 cells following FACS analysis using
integrin antibodies as described in Materials and Methods section. Relative fluorescence values were determined using the arbitrary geometric mean values
calculated for the individual histograms, from which the non - specific fluorescence was deducted. Non - specific fluorescence was measured in the absence of
antibody. Values are taken from a representative experiment in a series of three.
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although the details remain to be elucidated (reviewed in
Ref. [29] ). We therefore examined whether the MEK–ERK
signalling cascade was involved in integrin-mediated adhe-
sion assembly downstream of FAK in the colon epithelial
cells. Specifically, we monitored ERK activity using dual
phospho-specific ERK antibodies raised against a peptide
encompassing Thr183 and Tyr185 in their phosphorylated
forms. Using mild fixation and biotin–streptavidin amplifica-
tion in immunofluorescence procedures as described in
Fincham et al. [20], we detected phospho-ERK–specific
staining at newly formed cell–matrix adhesions as AA/C1/
SB10 cells spread on fibronectin (Figure 4A ). In particular,
phospho-ERK staining with three different antisera was
coincident with anti–vinculin staining at cell–matrix adhe-
sions. Data are shown for polyclonal anti -pT183EpY185 ERK
(Promega, Southampton, UK) and polyclonal anti -
pT183EpY185 (NEB, Hitchin, UK; Figure 4A ), and similar
results were obtained with polyclonal anti -pY185 ERK (NEB,
Hitchin, UK; not shown). Phospho-ERK was not present at
the cell periphery in the AA/C1 adenoma cells following
plating on fibronectin, and in these cells, it appeared to be
nuclear (Figure 4A, bottom panels ). We were also able to
visualize ERK localized at cell–matrix adhesion structures
following transient expression of epitope- tagged ERK in the
cells (Figure 4B ). There was a very high level of HA-ERK
expression in the cells, much of which was in the nucleus,
with some also being located at the protruding cell–matrix
adhesions. Treatment with PD098059 or UO126 — two
chemically distinct inhibitors of ERK kinase (MEK) [30,31],
the upstream ERK-activating kinase — both blocked the
targeting of phospho-ERK to the cell periphery (Figure 4C,
only treatment with PD098059 shown). In repeated experi-
ments, between 35% and 40% of the untreated cells had
phospho-ERK staining at the cell periphery and this was
inhibited by around 80% in the inhibitor - treated cells.
Since we had also observed that expression of FAK-
Y397F inhibited matrix-dependent adhesion assembly of
AA/C1/SB10 cells (Figure 3B ), we used the peripheral
targeting of phosphorylated ERK in individual cells to
determine whether there was a link between phosphorylation
of FAK on tyrosine-397 and ERK activity at the cell periphery
during the assembly process. We found that transient
expression of FAK-Y397F also inhibited the targeting of
phospho-ERK to the cell periphery (Figure 4D ), indicating
that FAK phosphorylation on tyrosine-397 was required for
this process. In repeated experiments, between 35% and
40% of the untreated cells had phospho-ERK staining at the
cell periphery and this was inhibited by around 95% in the
cells expressing FAK-Y397F. However, since the transient
transfection efficiency is relatively low in AA/C1/SB10 cells,
we were unable to determine whether FAK-Y397F inhibited
the phosphorylation and activation of ERK, or only its
peripheral targeting.
To address the role of the FAK–ERK pathway in the cell–
matrix adhesion assembly process, which is altered between
the adenoma and carcinoma cells, we treated the cells with
PD098059 or UO126. Both inhibitors of ERK activation
suppressed the assembly of cell–matrix adhesions in the
Figure 3. FAK phosphorylation is required for integrin -mediated adhesion
assembly. (A ) FAK phosphorylation in cells either held in suspension (Sus ),
plated on fibronectin (FN ), or poly - L - lysine (PL ) for 1 hour. FAK was
immunoprecipitated from cell lysates and tyrosine - phosphorylated FAK
visualized by blotting and probing with PY20, a general phosphotyrosine
antibody ( left hand, top panel ). The same filters were reprobed with anti –FAK
antibody ( left hand, bottom panel ). FAK phosphorylated on tyrosine -397 was
immunoprecipitated from AA /C1 /SB10 cell lysates using a phospho - specific
antibody and immunoprecipitated proteins visualized by probing with an anti –
FAK antibody ( right panel ). (B ) AA /C1 /SB10 cells were transfected with
Myc - tagged wtFAK or FAK-Y397F and trypsinized after 24 hours before
plating on fibronectin. After 1 hour, the cells were fixed and stained with an
antibody to vinculin and the Myc epitope tag. Cell –matrix adhesion assembly
was quantitated in the non - transfected and transfected cells. Values are
mean±SD from triplicate wells with >500 transfected cells. (C ) Visualization
of Myc - tagged proteins following double staining with anti –Myc and anti –
vinculin antibodies. Scale bars, 25 m.
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AA/C1/SB10 cells (Figure 5A ). Although treatment with
PD098059 or UO126 clearly caused a reduction in the
number of cells that formed cell–matrix adhesions (defined
as cells which had spread and contained vinculin-containing
structures at the cell periphery) at concentrations which
inhibited its peripheral targeting, we also found that these
vinculin-containing complexes were smaller and less pro-
trusive (Figure 5B, broken arrows ) than those seen in
untreated cells (Figure 5B, solid arrows ). Quantitation of this
showed that between 80% and 85% of the inhibitor treated
cells was unable to assemble protruding adhesions (Figure
5B, bottom panel ). Thus, inhibition of the MEK–ERK
pathway had a pronounced effect on the quality of cell–
matrix adhesions in AA/C1/SB10 colon carcinoma cells.
This suggests that although vinculin can still be incorporated
into small adhesion structures at the cell periphery in the
presence of selective inhibitors of MEK–ERK activity, these
are not able to convert to protrusive adhesions found in
untreated cells.
Figure 5. ERK is required for integrin -mediated adhesion assembly. (A )
Cell –matrix adhesion assembly on fibronectin in the presence of PD098059
(25 M) or UO126 (20 M) was measured by counting the percentage of
cells with prominent adhesions in >500 adherent cells. Values are mean±SD
from triplicate wells. (B ) Visualization of cell –matrix adhesions in untreated
and inhibitor - treated cells stained with anti – vinculin antibody. Scale bars, 25
m. Quantitation of cells with protruding cell –matrix adhesions from >500
cells ( lower panel ). Values are mean±SD from triplicate wells.
Figure 4. Localization of activated ERK in cell –matrix adhesions. (A ) Cells
were fixed after 1 hour on fibronectin and co - stained with anti –phospho -ERK
antibodies and an anti –vinculin antibody. Scale bars, 25 m. (B ) AA /C1 /
SB10 cells were transfected with HA - tagged ERK and trypsinized after 24
hours before plating on fibronectin. After 1 hour, the cells were fixed and
stained with an antibody to HA. Scale bars, 25 m. (C ) AA /C1 /SB10 cells
treated with PD098059 were fixed after 1 hour on fibronectin and co - stained
with anti –phospho -ERK antibodies and an anti – vinculin antibody. (D ) AA /
C1 /SB10 cells were transfected with Myc - tagged FAK (Y397F ) and, after
24 hours, trypsinized before plating on fibronectin. After 1 hour, the cells
were fixed and stained with an antibody to phospho -ERK and the Myc
epitope tag. Control cells were untransfected cells in the same culture. Scale
bars, 25 m.
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Actin Cytoskeletal Rearrangements during Cell–Matrix
Adhesion Assembly
As ERK was known to influence the actin cytoskeleton via
phosphorylation of MLCK [21] and as peripheral targeting of
active ERK was required for the full development of
protrusive cell–matrix adhesions in the colon carcinoma
cells, we examined the actin cytoskeleton in the colon
epithelial cells as they assembled adhesions on fibronectin.
Use of labeled phalloidin revealed a tight ring of cortical actin
in all cells; however, in AA/C1/SB10 cells that had
prominent cell–matrix adhesion protrusions, it was possible
to detect filamentous actin in microspike- like structures,
which emanated from the ring of cortical actin that
colocalized with the focal adhesion proteins vinculin and
talin (Figure 6A, arrow heads ). These actin-containing
microspikes were seen in around 35% of the AA/C1/SB10
cells, but were not seen in the AA/C1 adenoma cells and
vinculin-containing structures rarely protruded into the
extracellular space (Figure 6A, bottom panels ). Thus, the
protrusive stage of assembly of cell–matrix adhesions was
associated with the presence of filamentous actin spikes in
the cell protrusions. In accordance with a role for the actin
cytoskeleton in the protrusive stage of cell–matrix adhesion
assembly, treatment with the actin filament -disrupting drug
cytochalasin D prevented the assembly of actin microspikes
associated with vinculin -containing protrusions at the cell
periphery, but had no effect on the cortical ring of actin at the
cell periphery (Figure 6B ) or on the ability of the cells to
attach to fibronectin ( results not shown). As with the MEK
inhibitors, in cytochalasin D–treated epithelial cells, the
vinculin-containing complexes were confined to a ring of
non-protruding structures at the cell periphery, which were
reminiscent of the vinculin-containing structures in the
adenoma cells. Inhibition of MEK–ERK activation by
UO126 also blocked the formation of actin microspikes
(Figure 6B ), indicating that the activation of MEK–ERK, and
ERK activity at the cell periphery, is required for the actin
cytoskeletal rearrangements that accompany the final
protrusive stages of the cell–matrix adhesion assembly
process.
Discussion
Focal adhesions are points of cell–ECM contact, which are
found at the end of stress fibers in fibroblasts. The assembly
of stress fibers and focal adhesions is under the control of the
small GTPase Rho, now believed to be via stimulation of
myosin-based contractility that contributes to the bundling of
actin filaments into stress fibers after the clustering of
integrins at focal adhesions sites ( reviewed in Ref. [32] ). In
epithelial cells, the situation is complex as there are few
stress fibers, with the major actin structure being a peripheral
ring of cortical actin. For this reason, the control of cell–
matrix adhesion assembly in epithelial cells is not well
understood. In the AA/C1/SB10 colon carcinoma cells, we
found that upon initial integrin engagement, small structures,
which contained vinculin, formed on the basal surface of the
cell. We propose that these ring- like structures may
represent early ‘‘focal contacts’’ that comprise complexes
of focal adhesion proteins, which progress to form mature
cell–matrix adhesions seen as prominent vinculin-contain-
ing protrusions at the cell periphery. In this context, we have
demonstrated here for the first time a major role for ERK
activation in the latter stages of this process, as known
inhibitors of ERKs upstream-activating kinase MEK blocked
the full maturation of small focal contacts into the prominent
protrusive cell–matrix adhesions in the epithelial cells.
Phosphorylation and activation of FAK are associated
with attachment of cells to matrix proteins and we have
shown that phosphorylation of FAK on tyrosine-397 is also
required for the assembly of cell–matrix adhesions in the
colon epithelial cells (Figure 3B ). This is consistent with
other reports in CHO cells and fibroblasts where tyrosine-
397 is important for cell spreading [5,6,28]. Furthermore,
use of phospho-specific antibodies has shown that FAK
phosphorylated on tyrosine-397 is present in early focal
contacts, which are apparent during the initial spreading of
fibroblasts on fibronectin [33]. However, fibroblasts derived
from FAK-null embryos are not defective in focal adhesion
assembly and indeed have an increased number of focal
adhesions and impaired motility, suggesting a role for FAK in
focal adhesion turnover during cell motility in these cells [9 ].
Furthermore, phosphorylation of FAK on tyrosine residues
other than tyrosine-397 has been linked to focal adhesion
disassembly [23]. Taken together, these apparently dispa-
rate observations imply that phosphorylation of FAK on
tyrosine-397 is required for integrin-dependent adhesion
assembly in some cells such as the AA/C1/SB10 colon
carcinoma cells, in which endogenous FAK is present.
Although there was detectable FAK phosphorylation in the
AA/C1 cells (Figure 3A ), it was not sufficient to sustain the
elevated level of cell–matrix adhesion assembly seen in the
carcinoma cells. It may be that FAK phosphorylation is
limiting in this process, resulting in the inability of the AA/C1
cells to rapidly form adhesions on fibronectin (Figure 1B ).
There is a wide body of evidence implicating FAK in the
integrin-mediated activation of ERK. However, this area
remains controversial, with several studies favouring a
model in which integrin -mediated activation of ERK occurs
independently of FAK [34,35]. In this study, we have shown
that phosphorylation of FAK on tyrosine-397 is required for
the peripheral targeting of activated ERK to cell–matrix
adhesions, although we were unable to demonstrate
whether activation of ERK was inhibited or only its peripheral
targeting. However, expression of FAK-Y397F in human 293
cells does inhibit fibronectin- induced ERK activation [36],
which is consistent with a model whereby phosphorylation of
FAK on tyrosine-397 results in association of the non-
Figure 6. Actin rearrangements during cell –matrix adhesion assembly. (A ) Cells were fixed after 1 hour on fibronectin and co - stained with phalloidin –FITC and
either antibodies to talin or vinculin. (B ) As above, except AA /C1 /SB10 cells were pre - treated with cytochalasin D (0.25 g /ml ) or UO126 (20 M) for 15 minutes
prior to plating. Scale bars, 25 m.
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receptor tyrosine kinase Src with FAK, which in turn leads to
phosphorylation of FAK by Src on other residues including
tyrosine-925. This would in turn result in binding of the
adaptor protein Grb2 to FAK at tyrosine-925 and the
subsequent activation of the Ras–ERK cascade. Further-
more, the interaction of FAK with the non-receptor tyrosine
kinase Src, through interactions with tyrosine-397 of FAK,
plays a role in cell spreading and migration [5,28] and may
also play a role in the adhesion assembly process in the
colon epithelial cells.
The assembly of cell–matrix adhesions requires actin
cytoskeletal rearrangements and ERK may regulate adhe-
sion assembly through its effects on the actin cytoskeleton
[21,22]. In this regard, we observed in AA/C1/SB10 cells
with robust cell–matrix adhesions that filamentous actin was
found in microspikes present in these peripheral protrusions.
Treatment with cytochalasin D prevented the latter stages of
the adhesion assembly process, but did not disrupt cell
attachment and the formation of the smaller peripheral
adhesion complexes. Thus, the block in the cell–matrix
adhesion assembly process with cytochalasin D is analo-
gous to that seen when ERK was inhibited (Figure 5B and
6B ). Taken together with the observation that inhibition of
ERK activation also blocked the formation of the actin -
containing microspikes (Figure 6B ), this indicates that ERK-
mediated actin cytoskeletal rearrangements are required for
the protrusive stages of the cell–matrix adhesion assembly
maturation process.
We have recently shown that activated ERK locates to
newly forming adhesions in primary fibroblasts in response to
integrin engagement or v-Src activation [20], consistent with
earlier reports demonstrating accumulation of components
of the Ras–ERK signalling pathway to integrin-coated
beads [37]. In the colon epithelial cells used in this study,
we also found activated ERK in cell–matrix adhesions
following plating on fibronectin (Figure 4A ), suggestive of a
role for activated ERK at these adhesion sites. Several other
reports have also provided clues to the possible function of
integrin-mediated activation of ERK. In particular, MLCK has
been identified as an ERK substrate [21,38], and is required
for cell migration under some circumstances [21,22]. Thus,
since phosphorylation of myosin light chains by MLCK is a
critical step in generating contractile force, and actomyosin
contractility has been implicated in the process of integrin
clustering and focal adhesion assembly ( reviewed in Ref.
[32] ), it seems likely that ERK-mediated phosphorylation
and activation of MLCK may be involved in generating
contractile strength that results in actin microspike formation
required for the maturation of cell–matrix adhesions in AA/
C1/SB10 colon carcinoma cells. In the AA/C1 adenoma
cells, activated ERK was not present at the periphery in the
smaller number of cells that had assembled peripheral
complexes of adhesion proteins, although ERK was acti-
vated in the adenoma cells to a similar level as the carcinoma
cells ( results not shown). Thus, the inability of these cells to
efficiently assemble cell–matrix adhesions following integrin
engagement may be associated with the inability of activated
ERK to localize to newly forming adhesions at the cell
periphery. The mechanism of translocation of phosphory-
lated ERK to cell–matrix adhesions remains unclear. In this
context, it is interesting to note that activated MEK has also
been shown to locate at the plasma membrane under some
circumstances [39], and MEKK1, an upstream regulator of
c-Jun N- terminal kinase, can also localize to focal adhe-
sions [40]. Thus, there is evidence that a number of
components of the pathways leading to the activation of
MAPKs can locate at the cell periphery.
The observation, that v6 integrin function is required
downstream of attachment to fibronectin to induce matrix-
dependent adhesion assembly that is enhanced during
colorectal carcinogenesis in vitro, is particularly interesting.
v6 has been detected in a number of tumour cell lines and
also in material from tumour tissues of different origins,
including colon, being absent from normal adjacent tissue
[41,42]. Furthermore, in squamous cell carcinomas, 6
expression is restricted to the basal layer adjacent to stroma
and is, in many cases, concentrated at the invading edge of
tumour islands, suggesting a role for v6 in tumour cell
migration and invasion [41]. In addition, migration of
keratinocytes from 6  / mice on fibronectin is reduced
[27], indicating a role for the 6 integrin subunit in epithelial
cell migration. We observed a four- fold increase in v6
expression in the AA/C1/SB10 carcinoma cells compared to
the adenoma cells from which they were derived. Although
this represents a modest increase in cell surface integrin
expression, low levels of v6 have been shown previously
to mediate biological effects [43]. In tumour cells, upregu-
lation of FAK expression has also been associated with
enhanced motility [44], while enhanced FAK expression is
found in invasive tumours, including those of the colon
[45,46]. It is interesting that FAK expression is also
increased in AA/C1/SB10 carcinoma cells when compared
to the non-malignant AA/C1 progenitor cells [4 ], indicating
that a number of components associated with cell–matrix
adhesion assembly, such as v6 integrin and FAK, are
upregulated during the acquisition of the malignant pheno-
type in the AA/C1/SB10 cells [2,4 ]. Furthermore, EGF-
induced invasion of the AA/C1/SB10 carcinoma cells is
associated with phosphorylation of FAK, and also the
activation and localization of Src tyrosine kinase to cell–
matrix adhesions [4]. In contrast, the adenoma AA/C1
adenoma cells are non- invasive, suggesting that signalling
complexes at cell–matrix adhesions may regulate cell
behaviour associated with increased tumorigenicity.
Although we have shown an increase in v6 expression
associated with colon cancer progression, other integrins
which bind to fibronectin such as 51 are known to be lost
during the acquisition of a malignant phenotype. The balance
between adhesiveness and the ability of cells to move, which
is mediated by distinct integrin heterodimers, will therefore
govern the behaviour of tumour cells.
Conclusion
We have shown that increased expression of v6 integrin
during the adenoma-to-carcinoma transition in an in vitro
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model of colon cancer progression is associated with
increased integrin-mediated assembly of adhesions on
fibronectin. In addition, integrin-mediated adhesion assem-
bly requires ‘‘inside-out’’ signalling provided by phosphor-
ylation of FAK tyrosine-397 and peripheral translocation of
active ERK to newly assembling adhesions. Inhibition of
MEK–ERK activity suppressed both the number of cells that
assembled cell–matrix adhesions and the conversion of
smaller, perhaps immature, vinculin-containing structures
into fully developed, protrusive adhesions, most likely as a
result of inhibition of actin microspike formation at the cell
periphery.
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